companies innovating obesity treatment glp-1 drugs 2025 Pipeline Update: February - Prime Therapeutics Dozens of new obesity drugs

A light in the darkness: repetitive transcranial magnetic stimulation (rTMS) to treat the hedonic dysregulation of addiction

Prior authorization denial rates for GLP-1 obesity prescriptions have been high, and industry reporting through 2024 put them well above half of requests in some plans

Before attributing hair loss to aging alone, women should ask a clinician to check ferritin, thyroid function, and hormone levels, since correcting an underlying cause often produces better results than any peptide

334 A phase I study is ongoing to evaluate AG-270 in advanced solid tumors and lymphomas (NCT03435250)

Here is why

Prevention is Paramount: Employing sun protection for the genital area, adopting a balanced diet and healthy lifestyle, and understanding genetic risks are essential strategies to reduce the chance of developing the condition